Use of NSAIDs reduces progression-free survival of patients with mRCC
Non-aspirin non-steroidal anti-inflammatory medications have been found to have a negative impact on overall and progression-free survival time for mRCC patients...
List view / Grid view
Non-aspirin non-steroidal anti-inflammatory medications have been found to have a negative impact on overall and progression-free survival time for mRCC patients...
Scientists have developed a new test to diagnose peanut allergy that doesn't run the risk of false-positives or causing allergic reactions...
An Emulate, Inc. study has demonstrated that its Blood Vessel-Chip accurately modelled and predicted thrombosis, or clotting of blood, induced by certain monoclonal antibody drugs, specifically anti-CD154 monoclonal antibody (mAb) hu5c8.
The breast cancer drug lapatinib which is designed to shrink tumours can sometimes cause them to grow in the lab...
Wickham Laboratories CEO, Dr John McKenzie, will be presenting at the Cleanroom Technology Conference on the 16 May at 2:30PM, at the National Conference Centre in Birmingham...
Industry's fastest level scan function and LabSolutions UV-Vis control software...
New research could serve as the stepping-stone in constructing vaccines with a greater likelihood of finding and attacking...
Researchers are developing a pill that makes tumours light up when exposed to infrared light...
The FDA has approved Tafinlar in combination with Mekinist for the adjuvant treatment of patients with melanoma with BRAF V600E or V600K mutation...
The FDA granted Orphan Drug Designation to elamipretide, for the treatment of Leber's hereditary optic neuropathy...
3-D printing is an emerging technology that is impacting the way cardiologists treat patients with congenital heart disease...
Drug that strengthens blood vessels allows antibiotics to infiltrate tuberculosis granulomas in mice...
System detects direct signals of neural activity; could reveal patterns underlying behaviour...
The drug denosumab was superior to a commonly used drug in a 12-month study enrolling 795 patients...
Researchers have discovered why many multiple myeloma patients experience severe pain when treated with the anticancer drug bortezomib...